Redwood AI Corp. is a health care technology company specializing in artificial intelligence solutions for chemical and pharmaceutical development. It offers a proprietary AI-powered chemistry platform that predicts and optimizes synthesis pathways, accelerating drug discovery, molecular design, and material production. The platform integrates AI models, cheminformatics, and operational data to support synthesis planning, process optimization, and supply-chain decision-making, thereby reducing time, cost, and risk from early development through commercialization. Redwood AI Corp. serves the pharmaceuticals, biotechnology, and material sciences industries, enabling chemists to innovate faster and bring life-changing medicines to market more efficiently. Founded in 2022 and headquartered in Vancouver, British Columbia, Canada, the company provides these advanced software and analytics tools to drive breakthroughs in drug development and manufacturing.